Repligen Management
Management criteria checks 1/4
Repligen's CEO is Olivier Loeillot, appointed in Oct 2023, has a tenure of 1.17 years. total yearly compensation is $5.45M, comprised of 2.5% salary and 97.5% bonuses, including company stock and options. directly owns 0.003% of the company’s shares, worth R$1.62M. The average tenure of the management team and the board of directors is 1.9 years and 8.8 years respectively.
Key information
Olivier Loeillot
Chief executive officer
US$5.4m
Total compensation
| CEO salary percentage | 2.5% |
| CEO tenure | 1.2yrs |
| CEO ownership | 0.003% |
| Management average tenure | 1.9yrs |
| Board average tenure | 8.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$8m |
| Jun 30 2024 | n/a | n/a | US$9m |
| Mar 31 2024 | n/a | n/a | US$24m |
| Dec 31 2023 | US$5m | US$138k | US$36m |
Compensation vs Market: Olivier's total compensation ($USD5.45M) is above average for companies of similar size in the BR market ($USD2.32M).
Compensation vs Earnings: Insufficient data to compare Olivier's compensation with company performance.
CEO
Olivier Loeillot (54 yo)
1.2yrs
Tenure
US$5,445,065
Compensation
Mr. Olivier Loeillot is President of Repligen Corporation from October 02, 2023 & served as it's Chief Commercial Officer and serves as it's CEO & Director since September 1, 2024. Mr. Loeillot served a co...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chair | 9.6yrs | US$7.93m | 0.20% R$ 106.9m | |
| President | 1.2yrs | US$5.45m | 0.0031% R$ 1.6m | |
| CFO & Chief Compliance Officer | 1.3yrs | US$2.03m | 0.0013% R$ 689.7k | |
| Chief Operating Officer | 4.8yrs | US$3.74m | 0.0075% R$ 4.0m | |
| Senior Vice President of Research & Development | 8.2yrs | US$1.66m | 0.010% R$ 5.4m | |
| Chief Information Officer | no data | no data | no data | |
| Global Head of Investor Relations | no data | no data | no data | |
| Global Head of Legal | no data | no data | no data | |
| VP & Global Head of Sales | 2.2yrs | no data | no data | |
| Senior Director of Marketing | less than a year | no data | no data | |
| Vice President of Human Resources | 1.9yrs | no data | no data | |
| Senior VP of Strategy and Business Development & Global Head of Bioprocess Analytics | 4.9yrs | no data | no data |
1.9yrs
Average Tenure
60yo
Average Age
Experienced Management: R2GE34's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chair | 9.6yrs | US$7.93m | 0.20% R$ 106.9m | |
| President | less than a year | US$5.45m | 0.0031% R$ 1.6m | |
| Independent Director | 9.2yrs | US$322.84k | 0.056% R$ 29.7m | |
| Member of Scientific Advisory Board | 8.8yrs | no data | no data | |
| Independent Director | 1.8yrs | US$453.50k | 0.0070% R$ 3.7m | |
| Lead Independent Director | 19.3yrs | US$431.12k | 0.16% R$ 84.9m | |
| Member of Scientific Advisory Board | 8.8yrs | no data | no data | |
| Member of Scientific Advisory Board & Independent Director | 8.8yrs | US$282.84k | 0.00095% R$ 500.1k | |
| Member of Scientific Advisory Board | 8.8yrs | no data | no data | |
| Independent Director | 4.8yrs | US$287.84k | 0.0042% R$ 2.2m | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 10.5yrs | US$307.84k | 0.0071% R$ 3.7m |
8.8yrs
Average Tenure
64yo
Average Age
Experienced Board: R2GE34's board of directors are considered experienced (8.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 16:35 |
| End of Day Share Price | 2024/12/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Repligen Corporation is covered by 26 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Wasserman | Benchmark Company |
| Hugo Solvet | BNP Paribas Exane |
| Kyle Mikson | Canaccord Genuity |